NCT01320566View on ClinicalTrials.gov

A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

November 30, 2013

Conditions
Pulmonary EmphysemaChronic Obstructive Pulmonary Disease(COPD)Lung Diseases
Interventions
DEVICE

AeriSeal System

Not applicable. Follow-Up study only.

Trial Locations (2)

49100

The Rabin Medical Center, Petah Tikva

84101

The Soroka Medical Center, Beersheba

Sponsors

Lead Sponsor

Aeris Therapeutics
All Listed Sponsors
lead

Aeris Therapeutics

INDUSTRY

NCT01320566 - A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema | Biotech Hunter | Biotech Hunter